跳至主要内容
临床试验/ISRCTN34690731
ISRCTN34690731已完成未知

Multi-modality imaging to determine the role of calcification and inflammation on restenosis rates following lower limb angioplasty: The CIRLA Study

British Heart Foundation0 个研究点目标入组 50 人开始时间: 2017年8月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

2019 results in https://pubmed.ncbi.nlm.nih.gov/31202739/ (added 08/04/2020)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged 50 years or over (women aged 55 years or over)
  • 2. Symptomatic peripheral arterial disease (intermittent claudication / critical limb ischaemia)
  • 3. Undergoing superficial femoral artery angioplasty (PTA) or femoro-popliteal vein bypass graft (FPBG)
  • 4. Patients with TASC A and B lesions for the PTA group (there will be no restriction with regard to disease severity on the FPBG group as long as the anastomosis is to the popliteal artery)
  • 5. Taking standard antiplatelet/statin medication

排除标准

  • 1. Inability to undergo PET/CT
  • 2. Presence of end stage renal failure
  • 3. Metastatic malignancy
  • 4. Patients undergoing adjunct endovascular procedures in the infrainguinal segments – PTA group only (e.g. Bare Metal Stent, Drug Eluting Balloon, Drug Eluting Stent)
  • 5. Previous ipsilateral femoral artery angioplasty within the previous 6 months – PTA group only
  • 6. Women under the age of 55 years
  • 7. Patients with diabetes mellitus taking insulin

研究者

相似试验